ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026)
ClearPoint Neuro (CLPT) reported Non-Current Deffered Revenue of $608000.0 for Q1 2026, up 70.31% on a YoY basis from $357000.0 in Q1 2025, and up 4.65% sequentially from $581000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 9 years of Non-Current Deffered Revenue data on file, last reported at $608000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 70.31% year-over-year to $608000.0; the trailing twelve-month figure through Mar 2026 stood at $608000.0 (up 70.31% YoY), and the FY2025 full-year result was $581000.0, up 33.26% from the prior year.
- Non-Current Deffered Revenue rose to $608000.0 in Q1 2026, from $581000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $769000.0 in Q3 2025 to a low of $253000.0 in Q2 2023.
- A 5-year average of $466235.3 and a median of $446000.0 in 2024 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue sank 36.91% in 2023 and surged 76.28% in 2024, its largest moves.
- Tracing CLPT's Non-Current Deffered Revenue over 5 years: stood at $390000.0 in 2022, then jumped by 38.72% to $541000.0 in 2023, then fell by 19.41% to $436000.0 in 2024, then surged by 33.26% to $581000.0 in 2025, then advanced by 4.65% to $608000.0 in 2026.
- Business Quant data shows CLPT's Non-Current Deffered Revenue at $608000.0 in Q1 2026, $581000.0 in Q4 2025, and $769000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 608,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 608,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 769,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 458,000.00 |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 264,000.00 |
| Sep 30, 2021 | 310,000.00 |
| Jun 30, 2021 | 268,000.00 |